Becton Dickinson and Company (BDX) stock news · P/E 60, rev $21.84B
Becton Dickinson and Company (BDX) is a medical instruments & supplies company listed on US.
This BDX news page leads with what Becton Dickinson and Company filed — not a scraped headline mill.
No cached 8-K sentence for BDX yet. We will not pad this page with generic market recap.
Latest reported BDX revenue for 2025-09-30 was $21.84B. Net income was $1.68B. Revenue was up 8.2% from 2024-09-30 to 2025-09-30. BDX currently screens at market cap $50.30B and trailing P/E 59.9.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the BDX stock page; for the tape open the quote page.
BDX stock news FAQ
What are BDX's latest revenue and net income?
Latest cached Becton Dickinson and Company (BDX) revenue for Sep 30, 2025 was $21.84B. Net income was $1.68B. Statements: https://lician.com/financials/bdx
How did BDX revenue change from the prior cached period?
Cached Becton Dickinson and Company (BDX) revenue was up 8.2% from $20.18B (Sep 30, 2024) to $21.84B (Sep 30, 2025). Statements: https://lician.com/financials/bdx
What is BDX's P/E ratio?
Becton Dickinson and Company (BDX) trailing P/E is 59.9 on the latest cached fundamentals snapshot.
What is BDX's market cap?
Becton Dickinson and Company (BDX) market cap is $50.30B on the latest cached fundamentals snapshot.
What kind of company is BDX?
Becton Dickinson and Company (BDX) is a medical instruments & supplies company listed on US.
Where is BDX stock news listed?
Cached stock news for Becton Dickinson and Company (BDX) is listed at https://lician.com/news/bdx. Filings: https://lician.com/sec/bdx
Not investment advice.